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Abstract
The work deals with the determination of leptin and IL-6 influence on the development of immune disorders in patients 
with DM type 2 with hypothyroidism. There were examined 34 patients with diabetes mellitus type 2 and hypothyroidism and 
27 patients with the primary hypothyroidism without DM. It was revealed that obesity is characterized with an increase of leptin and 
IL-6 levels that, in its turn, condition the development of system inflammation of the low intensity and result in the increase of risk 
of autoimmune changes. In patients with DM type 2 in combination with hypothyroidism on the background of obesity the indices 
of leptin, IL-6, CD4+, CD8+ and IRI reliably differed from the ones in the group of patients without obesity that testifies to the 
negative influence of obesity on the development of autoimmune immunological disorders in patients with DM type 2. There were 
established the correlations between BMI and leptin and IL-6 CD4+, CD8+, ІRI indices in patients with DM type 2 in combination 
with hypothyroidism. 
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1. Introduction
According to the modern views, diabetes mellitus (DM) type 2 is not autoimmune disease; 
its pathogenesis is based on the disorder of sensitivity to insulin [1]. But it is well-known, that met-
abolic disorders favor the disturbances in immune system, especially, in patients with DM type 2 
takes place the metabolic immune suppression [2, 3]. 
Patients with DM type 2 are characterized with obesity (almost 90 %) that conditions the 
level of proinflammatory cytokines that complicate the existing immunologic disorders [4]. The 
proinflammatory cytokines are able to modulate immunological function through the several 
mechanisms which result is the disturbance of immune system that favor the autoimmune diseases 
that is why last years the significant attention of scientists was paid to the elucidation of the role of 
balance of proinflammatory cytokines in pathogenesis of autoimmune diseases [5, 6]. The value 
of immune suppression as the main factor of development of concomitant autoimmune diseases 
in patients with DM type 2 is persuasively proved by the series of researches that demonstrated 
that support of the rigid metabolic control allows improve immunological changes [7]. The timely 
diagnostics of concomitant autoimmune diseases of thyroid gland (TG) in patients with DM type 
2 and the further treatment are closely connected with the decrease of the risk of complications in 
the cardiovascular system and improvement of the life quality [8].
For today the role of adipocytokines, leptin and proinflammatory cytokines balance in the 
development of disorders in the immune system are actively studied [9–11]. Generally DM type 2 
with concomitant obesity and immune imbalance has the common pathophysiological mechanisms 
that are the chronic activation of immune system. There was accented the role of rise of TNF-α 
(tumor necrosis factor-α), Il-1β (interleukin-1β), IL-6 (interleukin-6), leptin content and decrease 
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of proinflammatory signal molecules that result in immune imbalance, including autoimmune pa-
thology [12–14].
For today the role of leptin in the development of autoimmune diseases is not finally es-
tablished [15]. There was detected the leptin ability to stimulate the cellular immune response 
and also its influence on phagocytic activity of macrophages with an increase of production 
of proinflammatory cytokines [16]. The numerous prospective cohort studies proved the de-
pendence between the concentrations of interleukin-6 (IL-6), mass of fatty tissue and insulin 
resistance (IR). It is known, that IL-6 has proinflammatory effect and influence the carbohy-
drate metabolism [17]. The value of immune suppression as the main factor of development 
of concomitant autoimmune diseases in patients with DM type 2 was persuasively proved by 
the series of researches that demonstrated that support of the rigid metabolic control allows 
improve immunological changes [18]. In most cases DM type 2 is combined with abdomi-
nal-visceral obesity [19]. The direct connection was demonstrated between the obesity degree 
and speed of development of manifestations and complications of DM type 2 [20]. That is why 
the treatment of patients with diabetes mellitus (DM) type 2 and concomitant primary hypo-
thyroidism must be directed on both compensation of metabolic disorders and normalization 
of changes in immune system [21]. 
2. Aim of research
Determination of the leptin and IL-contribution in the development of immune disorders in 
patients with DM type 2 and hypothyroidism. 
3. Materials and methods
The work is carried out on the base of department prophylaxis and treatment of diabetes 
mellitus in Ukrainian scientific-practical centre of endocrine surgery, transplantation of endocrine 
tissues and organs of MHP of Ukraine. 
The groups of patients with DM type 2 and hypothyroidism (n=34) and with primary hypo-
thyroidism without DM (n=27) were under observation. Patients with severe concomitant pathol-
ogy and heavy complications of the main disease that could have an influence on the indices of 
research were not included in the studied groups. 
The duration of DM and hypothyroidism was assessed according to the data of life and 
disease anamnesis and also according to the ambulatory case records of patients. Diagnosis di-
abetes mellitus was set on the WHO criteria of 1999. All patients underwent the complex clin-
ical examination taking into account complaints, anamnesis data (including family anamnesis: 
detection of the inherent inclination to DM, TG diseases, obesity; social anamnesis: feature 
of life style, food and harmful habits); objective (survey, palpation, percussion, auscultation) 
and additional (clinical, biochemical, immunological, hormonal and instrumental) methods of 
research. In patients were assessed the data of hormonal thyroid status on the levels of TTG, 
free thyroxin (fТ4), free triiodothyronine (fТ3), immune status by the determination of antibodies to 
the thyroid peroxidase (TPO). The glucose concentration in blood was determined by colorimetric 
method on automatic biochemical analyzer Sapphire-400, Tokio Boek L.T.D. Elitech diagnostics 
made by Seppin S.A.S. (France). The determination of glycated hemoglobin (HbA1c) concentration 
in blood was carried out by the method of high sensitive ion exchange liquid chromatography using 
automatic analyzed D-10 of BIORAD (USA) with the help of reagent D-10 Hemoglobin Testing 
System, Dual Program Recorder Pack (France). Assessment of the cellular link (Тх, cytotoxic lym-
phocytes level, immune regular index (Тх/cytotoxic lymphocytes) was based on the principle of 
markerogenic identification of sheep erythrocytes on the base of complementarity [6]. For studying 
the status of immune system of patients with DM in combination with hypothyroidism by immune 
peroxidase method using monoclinic antibodies was studied the content of lymphocytes subpop-
ulation in peripheral blood (percentage content: Т-lymphocytes (CD3+ – general Т-lymphocytes, 
CD4+ – Тх, CD8 – cytotoxic lympocytes), CD20+ lymphocytes (β-cells), NK-cells (CD16+) and 
proinflammaory cytokine concentration – IL-4. Erythrocytic diagnostics of detection of Т- and 
В-lymphocytes subpopulation was carried out by the sets of LD SPL “Granum” (Kharkiv city, 
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Ukraine) using the reaction of rosette creation with erythrocytes which the monoclonal an-
tibodies were adsorbed on (measurement diapason– 0–100 %; norm for CD3+ – 50–80 %, 
CD4+ – 33–46 %, CD8+ – 17–30 %, CD20+ – 11–16 %, CD22+ – 17–31 %, CD16+ – 12–23 %, 
CD95+ – 10–30 %). There was also studied the concentration of soluble form of Fas-receptor 
(CD95+) in blood serum [7]. Using immunosorbent method on «StatFax» analyzer were stud-
ied the IL-6 and leptin levels. IL-6 level was determined by quantitative method by the sets of 
reagents Pro Con IL-6 (St-Petersburg city, Russia) which principle is in the use of “Sandwich” 
variant of immunosorbent analysis with mono- and polyclonal antibodies (measurement diapa-
son – (0–250) pg/ml; norm – (0–10) pg/ml).
Statistical analysis included descriptive statistics, check of the character of indices distribu-
tion. The significance of differences was evaluated on the Student’s criterion (t) for the normal sings 
distribution. The differences with reliability level less than 0,05 were assessed as clinically signifi-
cant ones. All statistical calculations were carried out at the significance level 95 % (р = 0,05). At 
the distribution that differs from the normal one was used nonparametric method of calculation– 
U-Mann-Whitney criterion for two independent samples. The received data were present in the ta-
ble ant text as relative ones, values – (%), and also as (М ± m), where М – arithmetical mean value, 
m – standard mean error, Ме [25, 75] (Ме – median 25-th and 75-th quartiles). The differences were 
considered as statistically significant at р<0,05.
4. Results 
Patients with DM type 2 with hypothyroidism were from the older age group, had the reli-
able increase of BMI indices (р<0,001) comparing with patient with DM without hypothyroidism. 
The BMI rise was conditioned by abdominal obesity according to WS/HS indices. At abdominal 
obesity takes place the cytokines imbalance toward the rise of activity of proinflammatory cyto-
kines that supports the chronic inflammation of the low intensity. With age the content of fatty 
tissues increases and also raises the resistance to leptin and as the result its level increases. 
For the moment of examination carbohydrate metabolism in all patients was at the stage of 
decompensation. The mean HbA1c level was – 7,8 %, mean daily glycemia – 9,2 mmol/l in patients 
with DM type 2 in combination with hypothyroidism. In patients with DM lipidogram indices were 
significantly higher than in patients with DM type 2 in combination with hypothyroidism compar-
ing with patients with DM type 2 without hypothyroidism (р<0,001).
In patients with DM type 2 in combination with hypothyroidism on the background of obe-
sity the indices of leptin IL-6, CD4+, CD8+ and IRI reliably differed from the ones in the group 
of patients without obesity that indicates the negative influence of obesity on the development of 
autoimmune immunological disorders in patients with DM type 2 that can also favor the chronic 
inflammation. 
Median of the leptin level in examined patients with DM type 2 with hypothyroidism 
was 32,1 pg/ml that exceeded norm in more than 2 times and IL-6 level was 22,7 pg/ml that 
also exceeded norm almost twice (referent values 0-10 pg/ml). At comparative analysis in the 
groups of examined patients was established that leptin and IL-6 levels were reliably higher in 
patients with DM type 2 with hypothyroidism on the background of obesity than in the group 
of patients with DM type 2 without obesity (р<0,05). Median of CD4+ level in patients with 
DM type 2 with hypothyroidism was 4,6, CD8+, CD12+, at the same time the CD8+, lympho-
cyte-suppressor level was significantly lower comparing with patients with DM type 2 without 
obesity that proves the expressed immune suppression conditioned by the chronic inflamma-
tion and metabolic changes. In its turn, in patients with DM type 2 with hypothyroidism IRI 
median was significantly higher – 4,9. 
We also detected the correlations between BMI and leptin and IL-6, CD4+, CD8+, IRI indi-
ces in patients with DM type 2 combined with hypothyroidism (Table 1).
The researches revealed that leptin and IL-6 levels had a negative correlation with CD8+ – 
Т-cells-suppressors and positive one with CD4+ that has a significant value in pathogenesis of au-
toimmune diseases. It was proved, that leptin and IL-6 levels had a positive correlation with BMI. 
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Table 1
Coefficients of correlation of IL-6 and liptin with T-cellular link of immunity and BMI 
Index
BMI CD4+, % CD8+, % IRI
rs p rs p rs p rs p
DM type 2 with hypothyroidism
Leptin 0,82 р<0,05 0,83 р<0,05 0,87 р<0,05 0,8 р<0,01
IL-6 0,91 р<0,001 0,87 р<0,05 –0,8 р<0,01 0,92 р<0,01
DM type 2 without hypothyroidism
Leptin 0,76 р<0,01 0,68 р<0,05 –0,52 р<0,05 0,51 р<0,05
IL-6 0,67 р<0,05 0,53 р<0,05 –0,63 р<0,05 0,62 р<0,05
Notes: rs – rank coefficient of Spearman correlation; р – significance of indices differences
5. Discussion
Metabolic changes revealed in patients with DM type 2 and hypothyroidism in the further 
can deepen the shifts of immune status namely metabolic immune suppression that is characterized 
with decrease of CD8+ – cells level on which expense IRI increases that results in development and 
progressing of autoimmune disorders. 
Our results correspond to the ones of other authors [7, 11]. 
Obesity is characterized with an increase of leptin and IL-6 levels that, in their turn, con-
dition the development of system inflammation of low intensity and result in the rise of risk of 
autoimmune changes development. 
Taking into account the significant spread of DM, especially, type 2 and also autoimmune 
diseases in population for the last decade and the tendency to world population aging, the combi-
nation of DM type 2 with hypothyroidism is quite frequent [4, 19]. It is also important that mech-
anisms that participate in the lesion of organs and tissues in patients with DM type 2 are rather 
complicated but most likely they are based on both metabolic and immunological changes. At 
hyperglycemia many factors that in the normal state regulate the tissue homeostasis are intensified. 
It must be underlined that the aforesaid disorders are not specific for diabetes mellitus because they 
are very frequent at various lesions of inflammatory and degenerative character. In patients with 
DM these disorders are complicated with hyperglycemia and the other biochemical disturbances 
that appear on its background. The significance of hyperglycemia as one of the risk factors of auto-
immune disorders in patients with DM was demonstrated in several researches that proved that the 
support of rigid metabolic control allows normalize the immunological changes. 
At the same time at metabolic-immunological changes prescription of preparations that in-
fluence the pathogenetic mechanisms of the destructive processes development is needed. 
That is why we offer to study the content of lymphocyte subpopulation in peripheral blood 
and calculate the immune regulatory index for prognostication of development and progressing of 
existing concomitant autoimmune diseases in patients with diabetes mellitus type 2. 
The limitation of our research is in the insufficient number of examined. At the same time in the 
article is firstly considered the role of metabolic shifts and cytokine imbalance in the further development 
and progressing of autoimmune processes in patients with DM type 2 combined with hypothyroidism. 
6. Conclusions
There was established statistically significant increase of leptin and IL-6 levels in patients 
with DM type 2 and hypothyroidism at the reliable increase of lipid metabolism indices that testi-
fies to the metabolic immune suppression in conditions of cytokine imbalance. 
1. Leptin and IL-6 level in examined patients with DM type 2 and hypothyroidism exceeded 
the normal ones more than twice. 
2. There was revealed the clear positive interconnection between the leptin and IL-6 levels 
in patients with DM type 2 at obesity and the degree of the immune system activity. 
3. In patients with DM type 2 with hypothyroidism were detected immunological changes 
that in the further favor the development of autoimmune diseases. 
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Abstract
Surgical treatment was applied in 145 patients with complicated forms of chronic pancreatitis (CP) at the department of surgery of 
the Ivano-Frankivsk Regional Clinical Hospital in 2009–2016. Fourty-nine (33.7 %) patients had symptoms of biliary hypertension (BH); in 
five (3.4 %) of them BH was combined with chronic duodenal obstruction (CDO), the other 5 (3.4 %) patients had a combination of BH+C-
DP and local venous hypertension of pancreaticobiliary area vessels. Resection-type surgeries were applied in 28 (57.1 %) patients with CP 
complicated by BH. Intraoperative monitoring of biliary pressure was used in 17 patients in the process of duodenum-preserving resections 
of the pancreas. Frey’s procedure was applied to 20 (71.4 %) patients, in whom BH persisted after the resection stage of the surgery; Frey’s 
procedure was supplemented by interventions on bile ducts: hepaticoenteroanastomosis was applied in 12 patients, excision of pancreas 
lingula was applied in one patient, internal biliopancreatic anastomosis was applied in one patient. Berne modification was used in 2 (7.2 %) 
patients, and pancreaticoduodenal resection (PDR) according to Whipple – in 6 (21.4 %) patients. Remote results were studied in 19 (67.8 %) 
patients. Patients after duodenum-preserving resections had the best quality of life indicators, for BH signs were absent. 
Keywords: chronic pancreatitis, biliary hypertension, duodenum-preserving resection, biliary pressure, pancreatic-duode-
nal resection.
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